Literature DB >> 23869630

Management of placenta accreta.

Loïc Sentilhes1, François Goffinet, Gilles Kayem.   

Abstract

Cesarean hysterectomy is considered the reference standard treatment for placenta accreta. In young women who want the option of future pregnancy and agree to close follow-up monitoring, conservative treatment is a valid option. Several key points of both cesarean hysterectomy and conservative treatment remain debatable, such as timing of delivery, attempted removal of the placenta, use of temporal internal iliac occlusion balloon catheters, ureteral stents, prophylactic embolization, and methotrexate. In cases of placenta percreta with bladder involvement, conservative treatment may be the optimal management. Regardless of the chosen option, the woman and her partner should be warned of the high risk of maternal complications related to an abnormally invasive placenta.
© 2013 Nordic Federation of Societies of Obstetrics and Gynecology.

Entities:  

Keywords:  Abnormally invasive placenta; antenatal diagnosis; cesarean hysterectomy; conservative treatment; management; placenta accreta or percreta

Mesh:

Substances:

Year:  2013        PMID: 23869630     DOI: 10.1111/aogs.12222

Source DB:  PubMed          Journal:  Acta Obstet Gynecol Scand        ISSN: 0001-6349            Impact factor:   3.636


  16 in total

1.  Predelivery uterine artery embolization for placental anomalies: some clarifications.

Authors:  Shigeki Matsubara
Journal:  Radiol Med       Date:  2017-10-13       Impact factor: 3.469

Review 2.  The role of interventional radiology in the management of abnormally invasive placenta: a systematic review of current evidences.

Authors:  Philippe Soyer; Maxime Barat; Romaric Loffroy; Matthias Barral; Raphael Dautry; Vincent Vidal; Olivier Pellerin; Francois Cornelis; Maureen P Kohi; Anthony Dohan
Journal:  Quant Imaging Med Surg       Date:  2020-06

3.  Placenta Accreta and Total Placenta Previa in the 19th Week of Pregnancy.

Authors:  S Findeklee; S D Costa
Journal:  Geburtshilfe Frauenheilkd       Date:  2015-08       Impact factor: 2.915

4.  Latvian experience in conservative management of abnormally invasive placenta: two case reports.

Authors:  Diana Bokučava; Sandra Vītiņa; Maira Jansone; Mara Tirāne; Zane Krastiņa; Kristine Prostaka; Natalija Vedmedovska
Journal:  Acta Med Litu       Date:  2019

5.  Proposal of a simple 2-hand technique at cesarean hysterectomy for placenta accreta spectrum.

Authors:  Heather Miller; Ernesto Licon; Koji Matsuo; Nicole L Vestal; Jennifer L Sternberg; Shinya Matsuzaki; Lynda D Roman
Journal:  Arch Gynecol Obstet       Date:  2022-01       Impact factor: 2.344

Review 6.  Prevalence of abnormally invasive placenta among deliveries in mainland China: A PRISMA-compliant Systematic Review and Meta-analysis.

Authors:  Dazhi Fan; Song Li; Shuzhen Wu; Wen Wang; Shaoxin Ye; Qing Xia; Li Liu; Jinping Feng; Song Wu; Xiaoling Guo; Zhengping Liu
Journal:  Medicine (Baltimore)       Date:  2017-04       Impact factor: 1.889

7.  Ovarian reserve after uterine artery embolization in women with morbidly adherent placenta: A cohort study.

Authors:  Aya Mohr-Sasson; Maya Spira; Rony Rahav; Dafna Manela; Eyal Schiff; Shali Mazaki-Tovi; Raoul Orvieto; Eyal Sivan
Journal:  PLoS One       Date:  2018-11-29       Impact factor: 3.240

Review 8.  Pregnancy-Related Hysterectomy for Peripartum Hemorrhage: A Literature Narrative Review of the Diagnosis, Management, and Techniques.

Authors:  Dimitrios Tsolakidis; Dimitrios Zouzoulas; George Pados
Journal:  Biomed Res Int       Date:  2021-07-06       Impact factor: 3.411

9.  Retained Placenta Accreta Mimicking Choriocarcinoma.

Authors:  Maureen P Kohi; Gabrielle A Rizzuto; Nicholas Fidelman; Jennifer Lucero; Mari-Paule Thiet
Journal:  Case Rep Pathol       Date:  2015-10-01

10.  Escalating placenta invasiveness: repeated placenta accreta at the limit of viability.

Authors:  Shirley Greenbaum; Alla Khashper; Elad Leron; Eric Ohana; Mihai Meirovitz; Reli Hershkovitz; Offer Erez
Journal:  Int J Womens Health       Date:  2016-04-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.